CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with Relapsed/Refractory Microsatellite Stable Colorectal Cancer
Stock Information for Cytodyn Inc
Loading
Please wait while we load your information from QuoteMedia.